Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Health

KSU researcher receives grant for ASF vaccine research

KSU researcher receives grant for ASF vaccine research

MANHATTAN, KAN. – The Foundation for Food & Agriculture Research (FFAR) recently awarded a $1 million Seeding Solution grant to Kansas State University to develop rapidly deployable vaccines for African Swine Fever (ASF).

After the announcement, Elanco Animal Health, Kansas State University Innovation Partners and MEDIAN Diagnostics Inc., provided a matching fund that made up a total investment of more than $2.64 million.

FFAR emphasized that without a preventive vaccine or treatment, pork producers’ only control option would be enhancing biosecurity, increasing surveillance and quarantining or culling infected pigs.

“Should the virus reach the US, outputs from this research could slow the virus’ spread, protect millions of US pigs and safeguard our food supply,” said Jasmine Bruno, scientific program director for FFAR.

Although ASF has still not been discovered in the United States there have been recent detections in the Dominican Republic and Haiti.

“Producers need a way to protect their herds, as losses would be staggering not only for the pork industry, but also for other agriculture commodities that support the industry, like corn and soy,” FFAR said.

At KSU, Waithaka Mwangi, PhD, immunology professor in the Department of Diagnostic Medicine/Pathobiology, College of Veterinary, is continuing to develop and validate a vaccine that could protect pigs from the virus.

The research includes identifying which ASF proteins induce a protective immune response, the optimal dose needed for pigs, the most effective immunization platform, and a way to differentiate infected from vaccinated pigs. The research team is also addressing production constraints and safety concerns that would allow regulatory agencies to approve the vaccine.

Related Articles

UF researcher receives grant for beef cattle reproduction

Research firm nets grant for E. coli vaccine

University receives grant for E. coli research

Related Events

Meeting demand for clean label poultry with phosphate alternatives

European Veal: A Trusted Tradition

Enhance your industry IQ

Sign up for our free newsletters to stay informed on each day’s news and trends

Subscribe for Free

CURRENT ISSUES & DIRECTORIES

POPULAR ART

LEAVE A RESPONSE

Your email address will not be published. Required fields are marked *